New Classifications of Five Distinct “Sleep” Profi... ...
Science in the Age of AI | AI for Science Forum...
Ask the Heart Doctor | Heart Valve Disease and Sur...
High-speed imaging tracks live brain cell activity...
NAD⁺ restores memory in Alzheimer's disease models...
Mark Cuban: A Master Disrupter for American Health...
Teen girls facing the most adversity showed the biggest gain...
September 15,2026
Specialized imaging reveals hormone-driven brain changes...
September 14,2026
Submillimeter MRI reveals brain hubs that guide risky decisi...
September 12,2026
Risk of herpes zoster among breast cancer survivors in Japan...
September 11,2026
Three proteins help organs tailor shared circadian clock to ...
September 10,2026
Should you worry about melatonin and heart failure? The evid...
December 02,2025
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
GOSH BRC Showcase 2025 - Genomic medicine...
Can a twice-a-year shot help end the HIV...
Announcement of the 2025 Nobel Prize in ...
Reprogramming Stem Cells Could Cure Type...
Why MDMA did NOT get FDA approval...
More News
A step forward in the struggle against neuroblastoma, a type of childhood cancer

A step forward in the struggle against neuroblastoma, a type of childhood cancer

by University of SevilleCredit: CC0 Public DomainA group of researchers from the University of Seville and the Seville Biomedicine Institute (Instituto de Biomedicina de Sevilla—IBiS) has publish
Oncology March 09,2024
A step forward in the struggle against neuroblastoma, a type of childhood cancer

A step forward in the struggle against neuroblastoma, a type of childhood cancer

by University of SevilleCredit: CC0 Public DomainA group of researchers from the University of Seville and the Seville Biomedicine Institute (Instituto de Biomedicina de Sevilla—IBiS) has publish
Oncology March 09,2024
Genetic causes of tumors in salivary glands

Genetic causes of tumors in salivary glands

by University of Erlangen-NurembergCredit: CC0 Public DomainAcinic cell carcinoma is the third most common malignant form of salivary gland cancer. These tumours are similar to normal salivary gl
Oncology March 09,2024
Genetic causes of tumors in salivary glands

Genetic causes of tumors in salivary glands

by University of Erlangen-NurembergCredit: CC0 Public DomainAcinic cell carcinoma is the third most common malignant form of salivary gland cancer. These tumours are similar to normal salivary gl
Oncology March 09,2024
Washington University will open second proton center for cancer treatment as others shut down

Washington University will open second proton center for cancer treatment as others shut down

by Blythe BernhardCredit: CC0 Public DomainProton beam therapy, which has struggled to live up to its promise for treating cancer, is poised for a resurgence in St. Louis.As several otherproton&
Oncology March 09,2024
Washington University will open second proton center for cancer treatment as others shut down

Washington University will open second proton center for cancer treatment as others shut down

by Blythe BernhardCredit: CC0 Public DomainProton beam therapy, which has struggled to live up to its promise for treating cancer, is poised for a resurgence in St. Louis.As several otherproton&
Oncology March 09,2024
Current PSA monitoring ignores risk to some prostate cancer survivors

Current PSA monitoring ignores risk to some prostate cancer survivors

by Scott Maier,University of California, San FranciscoCredit: University of California, San FranciscoProstate cancer survivors make up the largest group, 41 percent, of male cancer survivors. In
Oncology March 09,2024
Current PSA monitoring ignores risk to some prostate cancer survivors

Current PSA monitoring ignores risk to some prostate cancer survivors

by Scott Maier,University of California, San FranciscoCredit: University of California, San FranciscoProstate cancer survivors make up the largest group, 41 percent, of male cancer survivors. In
Oncology March 09,2024
Whole-genome study of metastatic tumors provides a catalog of genetic features of metastatic cancer

Whole-genome study of metastatic tumors provides a catalog of genetic features of metastatic cancer

by Bob Yirka , Medical XpressCredit: CC0 Public DomainA team of researchers with members affiliated with multiple institutions in The Netherlands and Australia has conducted the largest-ever whole-gen
Oncology March 09,2024
Whole-genome study of metastatic tumors provides a catalog of genetic features of metastatic cancer

Whole-genome study of metastatic tumors provides a catalog of genetic features of metastatic cancer

by Bob Yirka , Medical XpressCredit: CC0 Public DomainA team of researchers with members affiliated with multiple institutions in The Netherlands and Australia has conducted the largest-ever whole-gen
Oncology March 09,2024
Only a third of women take up all offered cancer screenings, new research finds

Only a third of women take up all offered cancer screenings, new research finds

by King's College LondonCredit: CC0 Public DomainIn a paper published today in theJournal of Medical Screening, researchers from King's College London and Queen Mary University of L
Oncology March 09,2024
Only a third of women take up all offered cancer screenings, new research finds

Only a third of women take up all offered cancer screenings, new research finds

by King's College LondonCredit: CC0 Public DomainIn a paper published today in theJournal of Medical Screening, researchers from King's College London and Queen Mary University of L
Oncology March 09,2024
In high-risk neuroblastoma, two stem cell transplants may be better than one

In high-risk neuroblastoma, two stem cell transplants may be better than one

by Nancy Fliesler,Children's Hospital BostonCredit: Children's Hospital BostonSince the early 1990s, chemotherapy followed by an autologous stem cell transplant has been the standard of
Oncology March 09,2024
In high-risk neuroblastoma, two stem cell transplants may be better than one

In high-risk neuroblastoma, two stem cell transplants may be better than one

by Nancy Fliesler,Children's Hospital BostonCredit: Children's Hospital BostonSince the early 1990s, chemotherapy followed by an autologous stem cell transplant has been the standard of
Oncology March 09,2024
Atoh1, a potential Achilles' heel of Sonic Hedgehog medulloblastoma

Atoh1, a potential Achilles' heel of Sonic Hedgehog medulloblastoma

by Baylor College of MedicineThis is a cross-section of the cerebellum of a mouse. Found at the base of the brain, the cerebellum is a single layer of tissue with deep folds like an accordion. Th
Oncology March 09,2024
Atoh1, a potential Achilles' heel of Sonic Hedgehog medulloblastoma

Atoh1, a potential Achilles' heel of Sonic Hedgehog medulloblastoma

by Baylor College of MedicineThis is a cross-section of the cerebellum of a mouse. Found at the base of the brain, the cerebellum is a single layer of tissue with deep folds like an accordion. Th
Oncology March 09,2024
Women may not recognize non-lump symptoms of breast cancer

Women may not recognize non-lump symptoms of breast cancer

by Lori SolomonFewer than half of women recognize symptoms other than a lump in the breast as a potential sign of breast cancer, according to the results of a survey commissioned by The Ohio State Uni
Oncology March 09,2024
Women may not recognize non-lump symptoms of breast cancer

Women may not recognize non-lump symptoms of breast cancer

by Lori SolomonFewer than half of women recognize symptoms other than a lump in the breast as a potential sign of breast cancer, according to the results of a survey commissioned by The Ohio State Uni
Oncology March 09,2024
Cancer drug data release set to power next wave of therapeutic discovery

Cancer drug data release set to power next wave of therapeutic discovery

by Wellcome Sanger InstituteCredit: CC0 Public DomainThis week (25 July) the Genomics of Drug Sensitivity in Cancer project has released the results of four years of intense data gathering and explora
Oncology March 09,2024
Cancer drug data release set to power next wave of therapeutic discovery

Cancer drug data release set to power next wave of therapeutic discovery

by Wellcome Sanger InstituteCredit: CC0 Public DomainThis week (25 July) the Genomics of Drug Sensitivity in Cancer project has released the results of four years of intense data gathering and explora
Oncology March 09,2024
More News
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com